![{[Name]}](https://resource.bocsci.com/structure/3%27-azido-modifier-cpg-1000a.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/88192-19-2.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/2228857-31-4.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/72320-38-8.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/1240801-10-8.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/59090-48-1.gif?v=2025011501)
Inquiry Basket
Azido-PEG1-acid | CAS 1393330-34-1
| Catalog Number | R14-0290 |
| Category | Azides |
| Molecular Formula | C5H9N3O3 |
| Molecular Weight | 159.14 |
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
Azido-PEG1-C2-acid is a polyethylene glycol (PEG)-based PROTAC linker. Azido-PEG1-C2-acid can be used in the synthesis of a series of PROTACs.
Chemical Information
Product Specification
Computed Properties
Patents
| Related CAS | 1167575-20-3 (polymer) |
| Synonyms | N3-PEG1-COOH; Azido-PEG1-C2-acid; Propanoic acid, 3-(2-azidoethoxy)- |
| Purity | >95% |
| IUPAC Name | 3-(2-azidoethoxy)propanoic acid |
| Canonical SMILES | C(COCCN=[N+]=[N-])C(=O)O |
| InChI | InChI=1S/C5H9N3O3/c6-8-7-2-4-11-3-1-5(9)10/h1-4H2,(H,9,10) |
| InChIKey | JKOVLUVEHHGAEW-UHFFFAOYSA-N |
| Solubility | Water, DMSO, DMF, DCM |
| Appearance | Transparent Liquid |
| Storage | Store at 2-8°C |
| XLogP3 | 0.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 159.06439116 g/mol |
| Monoisotopic Mass | 159.06439116 g/mol |
| Topological Polar Surface Area | 60.9Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 164 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2012225089-A1 | Novel conjugates, preparation thereof, and therapeutic use thereof | 2009-06-29 |
| US-8952147-B2 | Conjugates, preparation thereof, and therapeutic use thereof | 2009-06-29 |
Recommended Services
Recommended Articles
- Hoechst Dyes: Definition, Structure, Mechanism and Applications
- Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
- Fluorescent Probes: Definition, Structure, Types and Application
- Fluorescent Dyes: Definition, Mechanism, Types and Application
- Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
- BODIPY Dyes: Definition, Structure, Synthesis and Uses
- Cyanine Dyes: Definition, Structure, Types and Uses
- Fluorescein Dyes: Definition, Structure, Synthesis and Uses
- Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
- Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
- Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
- Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
- Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
- DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
- Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
- Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
- Fluorescent Labeling: Definition, Principles, Types and Applications
Recommended Products
Online Inquiry
